pbcar0191, an allogeneic car t-cell therapy, in b-all
Published 2 years ago • 160 plays • Length 2:41Download video MP4
Download video MP3
Similar videos
-
1:26
an insight into ctx130: a novel allogeneic car-t cell therapy
-
1:49
a novel subcutaneous car-t therapy for the treatment of hematological malignancies
-
1:55
exploring first-line car-t therapy for the treatment of dlbcl
-
0:51
developing universal car-t therapies for t-all
-
2:20
design of a phase i trial of allogeneic anti-cd123 car t-cells in r/r aml
-
9:18
allogeneic car-t pbcar0191 with intensified lymphodepletion is highly active in pts with relapse...
-
7:36
star t-cell therapy for r/r b-cell all
-
3:05
car-t therapy in r/r dlbcl
-
2:05
the cost-effectiveness of car t-cell therapy
-
1:39
the role of myeloid cells in car-t cell therapy
-
8:27
anti cd7 car t-cell therapy in t-all
-
4:28
preliminary safety and efficacy of pbcar0191 in r/r cd19 nhl
-
1:02
the use of car-t cell products in a real-world setting
-
5:46
anti-cll1 car-t cell therapy in pediatric r/r aml
-
1:17
cart19-be-01 trial: next-generation car t-cell therapy for cd19 r/r leukemia and lymphoma
-
1:58
car t-cell therapy and all: the current landscape
-
5:14
novel synthetic tcr and antigen receptor (star) t-cell therapy for b-all
-
4:34
development and evaluation of a novel car-t cell therapy against calr mutant neoplasms